Elutia Inc.
ELUT- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001708527
No open-market purchases or sales by Elutia Inc. insiders were filed in the last 90 days; 39 institutions reported holding it in 13F filings for Q2 2026, worth $13.8M in total; no superinvestor holds it.
13F holders, Q1 2024
Institutional positions in Elutia Inc. as of Mar 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 22
- −2 vs. Q4 2023
- Shares held
- 5.69M
- −1.20M (−17.4%) vs. Q4 2023
- Total value
- $17.9M
- +$3.04M (+20.5%) vs. Q4 2023
- New holders
- 2
- 11 more added
- Sold out
- 4
- 3 more reduced
Compare with Q4 2023: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ELUT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 39 | $13.8M |
| Q1 2026 | 35 | $16.0M |
| Q4 2025 | 33 | $11.1M |
| Q3 2025 | 31 | $16.1M |
| Q2 2025 | 28 | $34.4M |
| Q1 2025 | 31 | $43.6M |
| Q4 2024 | 32 | $49.3M |
| Q3 2024 | 29 | $46.7M |
| Q2 2024 | 26 | $44.5M |
| Q1 2024 | 22 | $17.9M |
| Q4 2023 | 24 | $14.9M |
| Q3 2023 | 21 | $9.20M |
| Q2 2023 | 19 | $7.23M |
| Q1 2023 | 18 | $4.20M |
| Q4 2022 | 19 | $18.4M |
| Q3 2022 | 17 | $24.0M |
| Q2 2022 | 17 | $23.6M |
| Q1 2022 | 17 | $19.4M |
| Q4 2021 | 15 | $19.8M |
| Q3 2021 | 17 | $13.2M |
| Q2 2021 | 24 | $19.7M |
| Q1 2021 | 31 | $23.5M |
Institutions, Q1 2024
Shares, value and share of portfolio for each institution holding Elutia Inc.; share changes are against Q4 2023.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Birchview Capital, LP | 1,655,184 | $5.21M | 4.25% | 00.0% | Unchanged |
| Nantahala Capital Management, LLC | 1,650,000 | $5.20M | 0.51% | 00.0% | Unchanged |
| Perkins Capital Management Inc | 797,602 | $2.51M | 2.09% | +19,100+2.5% | Added |
| AIGH Capital Management LLC | 436,566 | $1.38M | 0.66% | −1,263,434−74.3% | Reduced |
| Vanguard Group Inc | 415,710 | $1.31M | 0.00% | +120,526+40.8% | Added |
| Knollwood Investment Advisory, LLC | 409,223 | $1.29M | 0.23% | +350,261+594.0% | Added |
| Geode Capital Management, LLC | 118,309 | $372.7K | 0.00% | +7,031+6.3% | Added |
| Silverarc Capital Management, LLC | 78,580 | $247.5K | 0.07% | +78,580 | New |
| Renaissance Technologies LLC | 35,616 | $112.0K | 0.00% | −5,561−13.5% | Reduced |
| Bank of America Corp | 23,584 | $74.3K | 0.00% | +23,579+471,580.0% | Added |
| Millennium Management LLC | 19,458 | $61.3K | 0.00% | −1,734−8.2% | Reduced |
| BlackRock Inc. | 15,238 | $48.0K | 0.00% | +1,975+14.9% | Added |
| Verdence Capital Advisors LLC | 14,410 | $45.4K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 13,809 | $43.5K | 0.00% | +485+3.6% | Added |
| Tower Research Capital LLC (TRC) | 5,274 | $16.6K | 0.00% | +1,449+37.9% | Added |
| US Bancorp | 625 | $1.97K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 500 | $1.57K | 0.00% | 00.0% | Unchanged |
| Federated Hermes, Inc. | 342 | $1.08K | 0.00% | +342 | New |
| Royal Bank of Canada | 239 | $1.00K | 0.00% | +129+117.3% | Added |
| Wells Fargo & Company | 112 | $353 | 0.00% | +2+1.8% | Added |
| JPMorgan Chase & Co | 24 | $76 | 0.00% | +11+84.6% | Added |
| Qube Research & Technologies Ltd | 1 | $3 | 0.00% | 00.0% | Unchanged |
| Worth Venture Partners, LLC | 0 | $0 | 0.00% | −478,542−100.0% | Sold out |
| Indie Asset Partners, LLC | 0 | $0 | 0.00% | −30,000−100.0% | Sold out |
| XTX Topco Ltd | 0 | $0 | 0.00% | −11,380−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −11,328−100.0% | Sold out |